Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection Within Approved Guidelines

Summary

Research Overview

Data for this study were conducted in an online survey instrument and through eight in-depth interviews with CI leaders and practitioners.

Study Objective and Methodology

The objective of this benchmarking study is tunderstand how U.S. pharmaceutical and biotechnology organizations can optimize their CI operations while working within defined guidelines.

Particular attention will be paid tCI information sources, what is being collected, and how CI groups work with legal groups tdevelop standard operating procedures for data collection that are in the best interests of the organization as a whole and tmaximize the CI departments ability tdeliver results.

Key Study Objectives

• Define range of useful and effective information sources
• Understand roles and mechanisms of data collection, assimilation, analysis, and dissemination
• Delineate the process of CI guideline development
• Provide examples of CI guidelines and how they are used
• Explore effective CI practices
• Describe best practices in developing and managing the CI function

Key Findings

Multiple Sources are Vital tEffective CI

• Triangulate from multiple data sources tdevelop the most accurate projections
• Critical types of secondary sources range from trade publications tinvestor feeds
• Integrate primary data with these existing sources

People, Processes and Use of Third Party Vendors are Keys tOptimizing Data Collection

• Hire the right people, utilize advanced Internet search techniques, collect and review data overtime tdistill relevant, actionable information
• Talk with employees across functions inside your company tdiscover information gaps
• Involve legal tmitigate risk if internal employees gather external CI information
• All large - and most small - pharma companies use vendors tminimize risk, tavoid the perception of wrongdoing, timprove the process, and get better finished intelligence
• Develop clear processes, practices and guidelines for all critical activities, such as collecting CI at trade shows

Contents

• Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection within Approved Guidelines
  • Table of Contents
  • Research Overview
  • Benchmark Class
  • Study Perspective
  • Scope of Benchmark Class
  • Definitions
• Key Findings and Insights
  • Data Sources
  • Multiple Sources Are Vital to Effective Ci
  • Must-Haves and Effective Secondary Sources
  • Small Pharma Relies Heavily on Secondary Sources
  • Large Pharma Rates Primary about Secondary Sources
• Optimizing Data Collection - People
  • People and Processes Are Keys to Optimizing Data Collection
  • Profile of The Best Ci Employee: Spotlight
• Optimizing Data Collection - Processes
  • Tap Internal Sources First
  • Vendors Collect Majority of Primary Ci Data
  • Most Small Pharma Employ Primary Ci Research Vendors
  • Large Pharma Outsource Primary Ci Research to Vendors
  • Holding Vendors to Strict Standards
  • Vendors Say They Do Not Misrepresent
  • Involve Legal to Decrease Risk
• Optimizing Data Collection - Practices
  • Employees across Functions Gather Data Points
  • Rich Conversations Stem from Effective Elicitation
  • Take The Team Approach at Conferences
  • Information about Pipeline Products Is Sought and Valued More Highly
  • Corporate Strategy Proves to Be Useful Data Point
  • Development and Examples of Ci Guidelines
  • Best Practices for Developing Ci Guidelines
  • Formal and Informal Policies Govern Ci Operations
  • Guidelines Encompass Ethics Code, Scip Policies & Laws
  • Ci Guidelines Include Specific Policies & Procedures
  • Prescribed Policies Govern Primary Data Collection
  • General Versus Prescribed Ci Policies: Spotlight
  • Legal Creates Guidelines for Small Pharma
  • Legal and Ci Work Collaboratively in Large Pharma
  • Creating Ci Guidelines with Legal: Spotlight
  • Ci Guidelines Enable Success
  • Train Ci & Non-Ci Employees on Guidelines
  • Effectively Train on The Guidelines: Spotlight
  • Executives Show Limited Support for Risky Ci Practices
  • Managing Expectations
  • Manage Expectations up Front
  • Educate The Requestor and Protect The Company
  • Rapid Response Team
  • Ci Plays Pivotal Role in Rapid Response Situations
  • Building a Successful Ci Function
  • Ci Executives Advise Emerging Ci Functions to Evolve
• about Best Practices, Llc